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Abstract
THE VENTILATORY RESPONSE TO NORMOXIC HYPERCAPNIA IN MALE
PET-1 KNOCKOUT MICE AND THE INFLUENCE OF FEMALE SEX HORMONES.
Simon R. A. Best and Matthew R. Hodges (Sponsored by George B. Richerson).
Department of Neurology, Yale University, School of Medicine, New Haven, CT.
Purpose: To determine if the deficiency in the hypercapnic ventilatory response as a
result of 70% loss of serotonergic neurons in male Pet-1 knockout mice and the sparing
of the female Pet-1 knockout mice can been accounted for and corrected by
supplementation with estrogen and progesterone.
Methods: Using whole-body flow-through plethysmography, 5 male Pet-1 -/- mice and 5
wild type mice were exposed to room air, 3%, 5%, 7%, and 10% CO2 and VE measured.
All mice were then treated with oral 17β-estradiol (2500 nM) for 48 hours followed by a
SC injection of progesterone (2 mg/kg). One hour after injection all plethysmography
studies were repeated.
Results: Before treatment Pet-1 knockout mice showed a trend towards decreased VE at
room air, 3%, and 7% CO2, with statistical significance at 5% CO2 (p <0.05), and an
identical VE only at 10% CO2. Absolute changes in VE after treatment were insignificant;
the differences in VE between genotypes achieved significance at control, 3%, and 5%
CO2 (p <0.05) while now VE at 7% and 10% CO2 exposures were identical (p < 0.05).
Conclusion: The partial recovery of the male Pet-1 knockout phenotype provides
evidence that the remaining serotonergic neurons can recover some chemoreceptor
function under the influence of female sex hormones, which in turn may partially explain
the female Pet-1 knockout phenotype.
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Introduction
As a neurotransmitter and a neural system, serotonin has been implicated in a
wide range of functions and disorders. These include the regulation of sleep, aggression,
anxiety, and clinical disorders such as depression, Obsessive Compulsive Disorder and
SIDS. While there is much clinical, pharmaceutical, and physiologic evidence to support
serotonin’s role in these various functions, little attention has been paid to a unifying
theory of the serotonin system that could account for these diverse roles. Given its small,
centrally located nuclei and its extensive connections throughout the CNS it is not
unreasonable to assume that some primary function could provide the key to its multifaceted phenotype.
Richerson has recently proposed central chemoreception as such a unifying
function for the serotonin system that takes into account some of primary properties of
serotonin neurons as well as provides an explanation for its role in these diverse disorders
(1).
Chemoreception is the “detection” component of the fundamental homeostatic
mechanism that is necessary to maintain a body pH between tight physiologic
boundaries. The primary determinant of pH in humans is carbon dioxide, through its
stochiometric and enzymatic conversion to bicarbonate and a proton (CO2 + H2O Æ H+ +
HCO3-). Therefore, candidate chemoreceptors must be able to respond to changes in pH
by initiating appropriate physiologic defense mechanisms. In the case of pH, the most
important acute response is the maintenance of PCO2 by the control of lung ventilation.
The first central chemoreceptors were located by focal acidosis of the cat medulla,
and an increase in ventilation was in seen on the ventrolateral surface (VLMS) (2). This
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is the location for the nuclei of multiple types of neurotransmitters, including serotonin,
whose medullary groups also include the raphe pallidus, raphe magnus, and raphe
obscurus (3). These serotonergic projections influence cardiovascular control, autonomic
output, motor control, and pain processing (4-6). They also have a well-described effect
on breathing. Respiratory nuclei including the nucleus ambiguous, nucleus tractus
solitarius, phrenic motor nuclei, hypoglossal nuclei, and the preBotzinger complex
contain serotonergic terminals (7-12). Exogenous application of serotonin analogues
stimulates respiration in rats and cats (13, 14). This effect is even more pronounced after
general anesthetic, where respiratory depression or apneusis can be reversed with
serotonin agonists (12, 15). Electrical stimulation of the raphe pallidus or glutamatergic
stimulation of the medullary raphe both increase phrenic nerve output (16, 17). As would
be expected, selective ablation of serotonergic nuclei leads to hypoventilation (18). In
sum, the primary respiratory effect of serotonin is a stimulation of breathing, thus, if it
could be shown that these neurons are chemosensitive, the hypothesis that serotonin
neurons in the VLMS are responsible for pH homeostasis would be an attractive one.
The lines of evidence that indicate serotonin neurons have the necessary
“detection” properties required for central chemoreception can be broken down into
broad categories - (1) in vitro work with single cell culture, (2) specialized anatomic
considerations, (3) in vivo studies with focal inhibition or destruction of serotonin
neurons, and most recently (4) genetic manipulation of the serotonin system.
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In vitro
The first clue that serotonergic neurons were involved in chemoreception came
from rat brain slices, where a subset of neurons in the medullary raphe were found to be
highly stimulated by changes in PCO2 from 5% to 9% and inhibited by change to a PCO2 of
3% (19). Another group of neurons showed an opposite response – they were inhibited
by acidosis and stimulated by alkalosis. Of these subsets, all carbon-dioxide stimulated
neurons were serotonergic, and none of the carbon-dioxide inhibited were. In cell culture
experiments it was determined that 75-90% of all serotonin neurons in the medullary
raphe respond to CO2 with an average response of 300% increase in firing frequency (2022). The channel responsible for this sensitivity appears to be a slow
afterhyperpolarixation calcium-activated cation current (23).

Anatomic Specialization
A striking structure-function relation exists for the serotonergic neurons in the
brainstem. Confocal studies show that serotonergic neurons wrap closely along side the
main arteries of the brain stem – the basilar artery and its penetrating branches – with
dendrites that enwrap the vessels and come with half of a micrometer from the arterial
blood (24). Teleologically, this is the ideal location for central chemoreceptors, as the
basilar artery contains blood with a PCO2 directly from the lung, reflecting gas exchange
before it is altered by brain metabolism. This anatomical specialization has not been
described in other putative chemoreceptors.
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In vivo
In whole animal studies there is also evidence that serotonergic neurons
contribute to the hypercapnic response. After hypercapnic exposure, C-fos staining
increases in CO2 activated neurons – these neurons in the medullary raphe are
immunoreactive for 5-HT and tryptophan hydroxylase (25, 26). In awake, normally
behaving cats, a subset of serotonergic neurons increases their firing rate in response to
exposure to CO2 (27). Two experiments inducing focal acidosis in the medullary raphe –
by application of acetazolamide or by microdialysis of high CO2 solution – both showed
an increase in ventilation (28, 29). Similar finding have been achieved in goats, where
focal acidosis in the medulla increases respiratory output (30, 31).
Experiments to inhibit or destroy serotonin neurons in the medullary raphe have
also shown the expected results. When neonatal rats are treated with 5,7-DHT, which
destroys serotonin neurons, in adulthood they have elevated PCO2 levels at baseline and a
decreased ventilatory response to CO2 (18). Focal lesions of the serotonin system in
adult rats with 8-OH-DPAT or antibody conjugated to the toxin saporin directed at the 5HT transporter cause a decrease in the ventilatory response to carbon dioxide (32, 33).

Genetic
Most recently, the ability to manipulate the serotonin system through genetic
knockouts eliminates the need for invasive or chemical manipulations (34). Due to the
high interest in the serotonin system for the study of behavioral and psychiatric systems,
many variant knockout mice have been developed. One knockout generated is deficient
in Pet-1, an ETS domain transcription factor critical for the normal development of
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serotonin neurons. Mice deficient in Pet-1 lack 70% of their serotonin neurons in all
serotonergic nuclei, with no detectable deficiencies in other neurotransmitter systems or
brain architecture. The remaining serotonin neurons have dramatically reduced TPH and
SERT mRNA expression. These deficiencies result in only 10-15% of wild-type
serotonergic fibers and quantitative levels of serotonin throughout the brain.
Behaviorally these mice are more aggressive than their wild-type kindred, but have
normal development, motor function and learning, reproduction, and life expectancy in
adulthood, although 30% of them die in the first week of life from unknown causes (35).
If the serotonin system was involved in chemoreception, Pet-1 knockout mice might be
expected to have a deficient response to hypercapnia if peripheral chemoreceptors and the
remaining serotonin neurons were unable to compensate sufficiently.
Indeed, recent studies with normoxic hypercapnic challenges have shown that
Pet-1 knockout mice do not have a normal response [Fig 1 (a)] (36). This deficit appears
to be mild, but when the results are sorted by the sex of the mice, a striking picture
emerges, where the male mice have a clearly deficient response [Figure 1 (b)] and the
female response is essentially normal [Figure 1 (c)]. This intriguing result suggests that
some factor or factors are responsible for protecting the female mice from the knockout
phenotype.
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The most obvious source of sex differences is the influence of the female sex
hormones estrogen and progesterone, especially since there is a well documented
stimulatory effect of female sex hormones upon breathing, primarily progesterone, in
humans and other species (37, 38).
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Sex Hormones and Respiration
Very early evidence for the effect of sex hormones on respiration was the
observation that pregnant women have decreased alveolar and arterial PCO2 (39, 40). The
same effect was also seen during the luteal of the menstrual cycle (41) and these cyclic
fluctuations disappeared after menopause (42). These observations were then correlated
with progesterone (43), and further in pregnant women as the log of serum progesterone
(44).
Progesterone was then shown to be a respiratory stimulant in normal, healthy men
(45) in multiple physiologic states including exercise and sleep (46). Clearly men do not
have the progesterone influence of pregnancy, but the one instance of a hyper
progesterone and estrogen state in males is cirrhosis of the liver. Cirrhotics have long
been known to have a baseline respiratory alkalosis, and when a group of patients with
liver disease were divided into those with severe or mild hyperventilation those with
greater hyperventilation had higher serum levels of estrogen and progesterone (47). It is
interesting to note that the levels of progesterone that apparently stimulated breathing in
cirrhotics were two orders of magnitude less than that in pregnant woman, which may
reflect different sensitivities to the effect of sex hormones.
These hormones may have an effect on common respiratory diseases in humans,
specifically Obstructive Sleep Apnea (OSA), which has a strong male predominance
(48). Women are protected until menopause (49) - 11% of premenopausal women
suffered from nocturnal desaturation, hypopneas or apneas during sleep in one study,
while 60% of postmenopausal women had the same symptoms (50). There is also
evidence that women taking hormone replacement therapies were protected (51).
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Synthetic progestins (most commonly Medroxyprogesterone [MPA]) were therefore used
as a treatment for OSA, and some studies showed improvements in blood gas levels,
sleepiness, and apneic events in males (52-54). Since estrogen increases progesterone
receptors (55) in females a combination hormone replacement therapy incorporating
estrogen reduced sleep associated breathing disorders (56-58).
The ventilatory effects of estrogen and progesterone have also been duplicated in
other animal systems. Guinea pigs (59), Jersey cows (60), rabbits (61), and goats (62)
hyperventilate when they are pregnant. However, chronic progesterone to male rabbits
and goats did not increase ventilation (63). Female rats do not have a ventilatory
response to MPA alone, although when MPA is combined with estrogen the number of
progesterone receptors increases and ventilation increases (64). This finding was
duplicated in male rats, where only the combination of estrogen and a progesterone
analog had an effect on arterial blood gas parameters (65). Work in cats showed the
same requirement for estrogen and progesterone and further refined the model by
blocking the response with an estrogen receptor antagonist, progesterone receptor
antagonist, and inhibitors of protein and RNA synthesis (66). Therefore it was concluded
that the ventilatory response is dependent upon both receptors as well as gene expression,
consistent with the known mechanism of steroid receptor activation.
There are a few mechanisms possible for the ventilatory changes seen as a result
of female sex hormones. The most attractive for the purposes of the current study is that
estrogen and progesterone alter the hypercapnic ventilatory response (HCVR) ie) they
influence central chemoreception. In men, administration of progesterone stimulated
ventilation and also increased the HCVR versus placebo without changing the hypoxic
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ventilatory response (45). In women, the change in ventilation in the luteal phase of the
cycle was shown to be due to a difference in the carbon dioxide sensitivity (67). In postmenopausal women administration of estrogen and progesterone combined with mild
exercise (to increase metabolic rate) caused an increase in ventilation that mimicked the
effects of pregnancy. The authors showed that both progesterone alone and the
combination of estrogen and progesterone caused a significant change in the HCVR (68).
Finally, in pregnant women themselves, a challenge with hyperoxic hypercapnia showed
a significant difference in both the HCVR and the threshold at which this response was
activated (69).
Certainly other mechanisms besides a change in the HCVR could be involved.
Both male and female rats express ERα, ERβ, and androgen receptors in the hypoglossal
and phrenic motoneurons and nuclei, although no progesterone binding was seen (70).
Sex hormones could be functioning as amplifiers of the normal HCVR simply by driving
stronger motor output. They could also change the basic respiratory rhythm, however,
there is no evidence that respiratory pattern generation generated by the pre-Bötzinger
complex is altered by sex hormones (38).

Female sex hormones clearly have an influence on respiratory parameters across a
wide variety of species, and perhaps even a specific effect on the hypercapnic ventilatory
response. Therefore we hypothesized that supplementation of the male Pet-1 knock-out
mice with physiologic levels of estrogen and progesterone would partially or completely
restore the deficiency in their normoxic hypercapnic ventilatory response.
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Statement of Purpose

The specific aims of this study were therefore:
1) To confirm the deficient ventilatory response of male Pet-1 knockout mice in
response to normoxic hypercapnic challenges through whole-body
plethysmography
2) Supplement the same male Pet-1 knockout mice with estrogen and progesterone
and quantify the change, if any, in their hypercapnic ventilatory response as a
result of hormone treatment
in order to:
Prove or disprove the hypothesis that the female sex hormones estrogen and
progesterone are responsible for the sex differences in the hypercapnic ventilatory
response of male and female Pet-1 knockout mice.
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Methods

The protocol followed for these experiments was based upon a modified
experimental design for previously published data (36) and approved for use by the Yale
Animal Care and Use Committee.
10 male PET-1 mice (5 PET-1 -/-; 5 PET-1 +/+) generated from a breeder colony
generously donated by the Deneris lab at Case Western were utilized for these
experiments. All animals were kept in the Yale Animal Care Facilities and provided
standard care – 12 hour diurnal cycles with freely available food and water.

Plethysmography
All plethysmography experiments were carried out in the following manner with
the investigator blind to the mouse genotype. The mouse to be studied was weighed prior
to experimentation and the ambient barometric pressure recorded. The mouse was then
placed inside the airtight plethysmography chamber [Figure 2 (a)] which was connected
to a gas manifold, a vacuum with a flow regulator, and a pressure transducer. When
sealed, the plethysmography chamber and pressure transducer records a change in
pressure that varies directly with the animal’s breathing as the inhaled gas is warmed and
humidified in the lungs (71). A custom designed Matlab 7.0.2 program then converted
the output voltage of the transducer into a linear trace of the pressure in the chamber,
while simultaneously recording the voltage at a sampling rate of 100 Hz. The pressure in
the box could therefore be monitored to insure an accurate ventilatory signal and prevent
a buildup of negative or positive pressure in the closed system. An extra chamber with a
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needle valve connected to the main plethysmography chamber provided an additional
pressure release point while buffering the chamber against sudden changes in
atmospheric pressure (such as a door opening in the laboratory). This design is consistent
with standard procedures for plethysmography experiments.

Needle Valve

O2 and
CO2

Syringe

Wall
Vacuum

Flow
Meter

Pressure
Transducer

Reference
Chamber

Stopcock

CO2 Tanks
0%

Calibration Port

3%
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7%

10%

RH/TC Port
Gas Outflow
Gas Inflow

Desiccant
Cylinder
Test Chamber

Gas Manifold

Figure 2 (a)

When placed in the plethysmography chamber each mouse was then exposed to a
set protocol of gases [Figure 2 (b)]. Each exposure was set at ten minutes to allow the
animal’s breathing to stabilize while minimizing fatigue. Ten minutes at room air (21%
O2, balance Nitrogen) was followed by ten minute exposures to CO2 mixes containing
3%, 5%, 7%, and 10% CO2 respectively with 21% O2 and balance Nitrogen. Every CO2
exposure was alternated with ten minutes of room air exposure to allow for multiple
sampling of the baseline ventilation and prevent respiratory fatigue secondary to
prolonged hypercapnic exposure. Connected in series with the plethysmography
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chamber was an O2 and CO2 analyzer which could verify the achievement of a stable CO2
exposure level. The mouse was continually monitored throughout the experiment to
maintain a state of quiet wakefulness, as sleep has an effect on the ventilatory response to
hypercapnia (72, 73). Ten second time periods of quiet breathing were noted throughout
the experiment to ensure usable data and marked for further analysis. At the end of each
set of plethysmography experiment a 1cc syringe was used to repeatedly inject 0.1cc of
air into the chamber with and without the mouse. This established a known volume to
voltage relationship which could then be used to calculate absolute tidal volumes for each
mouse.
Plethysmography Protocol
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Hormone Exposure
In order to test the hypothesis that the deficiency seen in the ventilatory response
of the male mice was a result of the relative lack of female sex hormones, the male mice
were supplemented with estrogen and progesterone in the following manner. Each
mouse served as its own control for these experiments, and was therefore studied in the
plethysmography chamber as outlined above on Day 0, immediately prior to commencing
hormone supplementation. The goal of hormone supplementation was to recapitulate as
closely as possible the normal serum levels of both female sex hormones in the male
mice, rather than administer a supra-physiologic dose. Normal female mice in their
normal estrus cycle have a serum estrogen between 10 and 30 pg/ml (74), and serum
progesterone between 10-60 ng/ml (75).
The adult male mice were treated with estrogen through their drinking water, as
oral estrogen has good bioavailability. 17β-estradiol was dissolved at a 20 mM
concentration in 95% ethyl alcohol (EtOH) and then diluted to a concentration of 2,500
nM in the standard chlorinated drinking water of the mice. Their daily water intake was
then substituted with the estrogen drinking water. Preliminary supplementation in nonexperimental mice had already been undertaken to show that Pet-1 mice drank the
supplemented water and achieved their daily intake needs without dehydration. Estrogen
drinking water at 2,500 nM dose has been shown to correspond to an estrogen serum
level of 38 pg/ml – at the high range of estrogen throughout the normal mouse estrus
cycle (76). Each experimental mouse had access to the estrogen drinking water for 48
hours, immediately following their control protocol in the plethysmography chamber.
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Stable plasma levels of estrogen would be expected within six hours of oral
administration, well within the exposure duration for this experiment (77).
As progesterone is extensively metabolized by the liver on first pass and therefore
has poor oral bioavailablity it is most commonly administered by intramuscular injection
or subcutaneous capsules. Although progesterone has a half-life in circulation of only 5
minutes, suspension in sterile sesame oil allows for a depo-like effect with slowly
declining serum levels after a single injection or implantation (78, 79). Experiments in
humans have shown that injection at a dose of 1.5 mg/kg achieves a serum level between
5 and 50 ng/ml over 48 hours (78), slightly lower than the normal level in mice. The
male mice therefore received a subcutaneous injection of 2 mg/kg of progesterone
suspended in 0.1 mL of sterile sesame oil one hour before the plethysmography
experiment.
It was noted during the course of these experiments that following the injection
some sesame oil would be expressed back out of the injection site, usually following
vigorous motor activity. While this would have reduced the total progesterone dose
received by the mouse, the pharmacokinetics of progesterone is such that the dose
injected has less of an impact on peak plasma levels than on the duration of the elevation.
In humans, a dose one quarter of the dose utilized in these experiments achieves similar
peak plasma levels of progesterone, however, the duration of the elevation is shortened
from 24 hours to 12 hours (78). Qualitative assessment after depositing 0.1 mL of
sesame oil directly onto the skin of a mouse suggested that much greater than 50% of the
injected dose remained subcutaneous throughout the experiment. As the experiments

21
lasted for approximately 3 hours post-injection, even 50% of the injected dose would
produce target plasma levels for many hours longer than required.

Data Analysis
The voltage vs. time data was recorded for each experiment in MatLab file
format, according to the previously described protocol. Another custom-designed
MatLab 7.0.2 was used to access this file and display it in plotted form, where the data
could be explored for ten second segments of quiet breathing, without mouse movement,
sniffing, or sighs. Breaths during the segment were identified by the peaks and troughs
of the voltage, and the interspike interval and amplitude was averaged across all breaths
in the segment. This procedure was repeated across all CO2 exposure levels with the goal
of finding at least six ten second segments of useable data during each gas exposure. The
mean interbreath interval and amplitude along with standard deviations were then
calculated for each gas exposure by averaging the values from the ten second segments.
The final room air interbreath interval and amplitude was obtained by an average of all
five ten minute exposures to minimize the effect of escalating CO2 on baseline
ventilation. The volume calibration performed with the mouse in the chamber was then
used to assist calculations of the absolute tidal volumes from the average voltage
deflection per breath in the following manner.
Since the pressure exerted by any gas varies with its temperature and partial
pressure of H2O, the air warmed and humidified by the lungs expands, and increases the
pressure in the sealed chamber upon inhalation. The chamber temperature (Tc) and
relative humidity (both measured parameters) are used to calculate the partial pressure of
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water in the chamber (PcH2O). The animal’s pulmonary temperature is assumed to be
equal to the animal’s body temperature (Ta), with the relative humidity of the inspired air
equal to the saturation humidity at that temperature. Because the animal’s temperature
was not directly measured in these experiments, it was assumed to be 37° C for all
animals and the water pressure of pulmonary air calculated (PaH2O). The known
calibration volume (Vcal) injected into the chamber that causes a known pressure change
(Pcal) was used to scale the following formula derived from the ideal gas law, where Pb
is the ambient barometric pressure and where A equals the voltage deflection of the
animal’s breath (80):

VT = A (Vcal / Pcal) [Ta(Pb – PcH2Ο)] / [[Ta(Pb – PcH2Ο)] - [Tc(Pb – PaH2Ο)]]

As the frequency of respiration is easily generated from the interbreath interval
(Frequency = 1 / IB Interval), absolute ventilation (VE) can be calculated by taking the
frequency multiplied by tidal volume.

VE (mL / minute) = Frequency * VT

Since the absolute tidal volume (mL) depends on the size of the mouse and the
relative size of its lungs, pooling data from all mice require that both VT and VE be
scaled. A surrogate and more easily measured variable for total lung capacity is the
weight of the mouse. VT and VE are therefore reported as adjusted for mass - VT (mL / g)
and VE (mL / minute/ g).
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For every mouse a respiratory frequency, VT, and VE were calculated for each ten
minute gas exposure (Room Air, 3%, 5%, 7%, and 10% CO2). As explained above, in
order to minimize variability in the control measurement as a result of escalating CO2, the
final control frequency, VT, and VE were obtained by an average of all five control
exposures. These results were then pooled and sorted by genotype with statistical
significance determined by the Paired Student’s T-test.

Results

Consistent with the previous experiments on Pet-1 mice, a deficiency in their
ventilatory response to normoxic hypercapnia was seen across multiple CO2 levels. Seen
side-by-side, the ventilatory tracing of a Pet-1 knockout mouse can be readily
distinguished from a wild-type mouse across multiple CO2 exposures [Figure 3].
Before hormone treatment each genotype’s ventilatory response was characterized
according to tidal volume, frequency, and ventilation (VE) [Figure 4 (a), (b), (c)]. Little
difference was seen in tidal volume between the wildtype versus knockout – at Room Air
(1.54 ± 0.08 vs. 1.37 ± 0.11 ml/g), 3% CO2 (2.00 ± 0.18 vs. 1.72 ± 0.13 ml/g), 5% CO2
(2.18 ± 0.16 vs. 1.83 ± 0.17 ml/g), 7% CO2 (2.31 ± 0.16 vs. 2.13 ± 0.10 ml/g), and 10%
CO2 (2.48 ± 0.17 vs. 2.49 ± 0.12 ml/g) these differences were not statistically significant
(p >0.05 for all data points).
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A different result was seen for frequency. Across most of the range of CO2
exposure there was a statistically significant difference between the wildtype and
knockout mice. At 3% CO2 (282 ± 10 vs. 242 ± 8 breaths/minute; p <0.05), 5% (301 ±
14 vs. 260 ± 8 breaths/minute; p <0.05), and 7% (315 ± 14 vs. 270 ± 11 breaths/minute; p
= <0.05) the difference in frequency was statistically significant. As would be expected
if the baseline ventilation was unaffected, the control respiratory frequency was not
statistically significant between the two groups (179 ± 10 vs. 167 ± 10 breaths/minute; p
= NS). Interestingly, the breathing frequency was similar between the two groups at 10%
CO2 as well (308 ± 12 vs. 290 ± 7 breaths/minute; NS).
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The difference in respiratory frequency therefore accounts for most of the
difference in overall ventilation between the two groups. There was a trend towards
lower overall ventilation under control conditions in the knockouts (028 ± 0.02 vs. 0.23 ±
0.02 ml/min/g; NS). The same trend was noted across all gas exposures up to 10% CO2
although it achieved statistical significance only at 5% CO2: 3% CO2 (0.57 ± 0.07 vs.
0.42 ± 0.04 ml/min/g; NS), 5% CO2 (0.66 ± 0.06 vs. 0.48 ± 0.04 ml/min/g; p <0.05), and
7% CO2 (0.73 ± 0.06 vs. 0.58 ± 0.05 ml/min/g; NS). At 10% CO2, the knockout’s
ventilatory response has clearly recovered to equal that of the wildtype (0.76 ± 0.06 vs.
0.72 ± 0.04 ml/min/g; NS). This result could suggest that mechanisms other than the
serotonin system could assist in the ventilatory response under extreme duress and will be
more fully discussed later.
Graphing the results as percent change from the control exposure gives a different
perspective on these results [Figure 4 (d)]. The hypercapnic ventilatory response
(HCVR) is usually determined from the slope of the CO2 response across multiple CO2
levels (ΔVE/ΔFICO2). As seen from the % Response curve for the wildtype and knockout
mice each genotype has a change in ventilation from their baseline, although as discussed
previously, the absolute ventilation across multiple carbon dioxide levels trends lower at
all hypercapnic exposures other than 10% CO2.
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Figure 4 (d)

Hormone Therapy
After acute treatment with hormone therapy the same ventilatory parameters were
measured again [Figure 5 (a), (b), (c)].
As seen before hormone therapy, there was no difference between the wild type
and knockout groups in tidal volume, nor were the tidal volumes increased consistently as
a result of the hormones. At all exposures there was not a statistical difference between
the groups: control (1.48 ± 0.05 vs. 1.35 ± 0.07 ml/g; NS), 3% CO2 (1.88 ± 0.07 vs. 1.62
± 0.09 ml/g; NS), 5% CO2 (1.95 ± 0.09 vs. 1.95 ± 0.1 ml/g), 7% CO2 (2.07 ± 0.12 vs.
2.20 ± 0.12 ml/g), and 10% CO2 (2.29 ± 0.1 vs. 2.50 ± 0.15 ml/g).
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Figure 5 (a)

Similar to the results seen before hormone therapy, the ventilatory frequency was
the respiratory parameter that showed the most difference between the two groups. At
room air (195 ± 8 vs. 154 ± 11 breaths/minute; p <0.05) and all carbon dioxide exposures
up to 7% CO2 there was a significant difference between the two genotypes: 3% CO2
(294 ± 7 vs. 225 ± 10 breaths/minute; p <0.001), 5% CO2 (300 ± 10 vs. 248 ± 6
breaths/minute; p <0.005). At 7% CO2 (308 ± 11 vs. 282 ± 13 breaths/minute; NS) and
10% CO2 (307 ± 9 vs. 278 ± 13 breaths/minute; NS) there was no statistical significance
between the groups. Therefore, hormone therapy with estrogen and progesterone did not
alter the basic characteristics of the differences in hypercapnic ventilatory response
between the two genotypes.
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Figure 5 (c)
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Total ventilation continued to be reduced in the knockout mice at control and
lower CO2 levels even after treatment with estrogen and progesterone, although the
ventilation recovery seen in the knockout mice at the highest CO2 exposure was now
obvious at both 7% and 10% CO2. The difference between the groups was statistically
different at room air (0.29 ± 0.02 vs. 0.21 ± 0.01 ml/min/g; p <0.005), 3% CO2 (0.55 ±
0.03 vs. 0.37 ± 0.02 ml/min/g; p <0.0005), and 5% CO2 (0.58 ± 0.03 vs. 0.48 ± 0.02
ml/min/g; p <0.05). After treatment total ventilation at both 7% CO2 (0.64 ± 0.06 vs.
0.62 ± 0.06; NS) and 10% CO2 (0.71 ± 0.05 vs. 0.70 ± 0.07 ml/min/g; NS) was not
statistically different. This result could suggest that the mechanism that responds to
higher levels of hypercapnic stress is hormone sensitive.
This finding is emphasized by a plot of the ventilatory response compared as a
percent to the baseline room air breathing [Figure 5 (d)]. Before treatment the knockout
group had a similar slope to the wildtype, but under the influence of female hormones it
shows a more robust response, especially at the higher CO2 levels. However, this trend
was not statistically significant: 7% CO2 (227 ± 27 vs. 305 ± 33 % response; NS) and
10% CO2 (250 ± 25 vs. 344 ± 41 % response; NS).
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Figure 5 (d)

When comparing the absolute ventilation with and without hormones there are
little differences between the wildtype or knockout groups to suggest that absolute
ventilation changed as a result of hormone treatment [Figure 5 (e)]. At room air and
across all CO2 exposures there was no significant change in VE in the wildtype group:
room air (0.28 ± 0.02 vs. 0.29 ± 0.02 ml/min/g), 3% CO2 (0.57 ± 0.07 vs. 0.55 ± 0.03
ml/min/g), 5% CO2 (0.66 ± 0.06 vs. 0.58 ± 0.03 ml/min/g), 7% CO2 (0.73 ± 0.06 vs. 0.64
± 0.06 ml/min/g), and 10% CO2 (0.76 ± 0.06 vs. 0.71 ± 0.05 ml/min/g). Therefore it does
not appear that this level of acute supplementation with female hormones stimulated
breathing in the wildtype mice.
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Similarly there was no difference in absolute ventilation in the knockout group as
a result of hormone treatment when directly compared to the pretreatment ventilation:
room air (0.23 ± 0.02 vs. 0.21 ± 0.01 ml/min/g), 3% CO2 (0.42 ± 0.04 vs. 0.37 ± 0.02
ml/min/g), 5% CO2 (0.48 ± 0.05 vs. 0.48 ± 0.02 ml/min/g), 7% CO2 (0.58 ± 0.05 vs. 0.62
± 0.06 ml/min/g), and 10% CO2 (0.72 ± 0.04 vs. 0.70 ± 0.07 ml/min/g).
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Figure 5 (e)

The higher percentile response seen after hormone treatment in the knockout
group is due to a combination of factors – a slight decrease in the room air ventilation for
the knockout group versus a slight increase the wildtype, along with a small decrease in
the overall response of the wildtype that magnifies the effect of an identical response in
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the knockout group. Therefore it can be concluded that supplementation with female sex
hormones did not significantly impact the absolute ventilation of either the wildtype or
knockout Pet-1 mice, but there is evidence that it changed the relative response between
the groups at higher CO2 exposures.

Discussion

The goals of this study were to 1) confirm and further define the deficiencies of
the Pet-1 male’s response to normoxic hypercapnia and to 2) determine if this deficiency
could be accounted for and corrected by physiologic supplementation with female sex
hormones.
In a confirmation of previously obtained results, the Pet-1 knockout mice showed
a statistically significant deficiency in their total ventilation, mainly at lower hypercapnic
exposures. The trend seen pre-treatment did not achieve statistical significance except at
5% CO2 most likely because of the small sample size. However, as their room air
ventilation was also depressed relative to the wildtype mice, their ventilatory response
seen as a percentage of baseline was not different than the respiratory response of the
wildtype. This raises the important question of the most accurate determinant of the
hypercapnic ventilatory response. The HCVR is most commonly expressed as the slope
of VE, which takes into account both the baseline ventilation and the hypercapnic
ventilation; by this measure the Pet-1 knockout mice do not show a difference in their
HCVR.
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Despite this result, there is a clear phenotype for the male Pet-1 knockout mice
compared to their wildtype kin. Their total ventilation is reduced both at room air and for
all hypercapnic exposures except 10% CO2. As is readily evident from the VE graph, the
decrease from the wildtype ventilation is not equivalent across all exposures, as might be
expected if the loss of serotonergic neurons interfered with the fundamental mechanisms
of breathing such as respiratory pattern generation, phrenic discharge, or diaphragmatic
function. At room air, the knockout’s VE is 82% that of wildtype, 74%, 73%, and 79% at
3%, 5% and 7% CO2 respectively and finally 95% at 10% CO2. These variable results
argue strongly that the disruption of the serotonin system in the Pet-1 mice does have an
effect on the hypercapnic ventilatory response, but also that this effect is not uniform
across the possible range of hypercapnic stressors. It could be concluded therefore, that
the serotonin system plays an important role in maintaining baseline ventilation and the
response to CO2 at lower exposure levels, and that a secondary hypercapnic response
independent of the serotonin system can assist in driving ventilation at higher carbon
dioxide stresses.
There is a precedent for this result in other knockout genotypes also deficient in
the serotonin system. Mice deficient in Lmx1b (a transcription factor necessary for
neuronal development (81) driven by the Pet-1 promoter are more severely deficient in
serotonin neurons than the Pet-1 knockout mice. These mice lack up to 99% of their
serotonergic neurons in all serotonin nuclei. When tested in whole body
plethysmography in a fashion similar to the Pet-1 mice, although using hyperoxic
hypercapnia to disable peripheral chemoreceptors rather than normoxic hypercapnia,
these mice show a more profound deficiency in their HCVR across a range of CO2
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similar to the results reported here [Figure 6]. The slope of VE is linear (representing the
HCVR) until 10% CO2, where a more robust ventilatory response is seen. This biphasic
response suggests that the serotonin system is functioning as a central chemoreceptor
responsible for driving a ventilatory response to CO2, but also that secondary neural
systems can “rescue” the response under severe enough acidosis.
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Figure 6

Seen in this context, the results from the current study support the theory of the
serotonin system as a central chemoreceptor, albeit one whose effect is not constant
across the entire range of hypercapnic challenges. However, the 70% loss of serotonin
neurons appears to have only resulted in a ~25% loss of ventilatory response. What
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could account for this difference if the hypothesis that serotonin contributes to the HCVR
is accepted?
First, the experiment performed here took place under normoxic conditions. As
has been well-described, peripheral chemoreceptors located in the carotid body provide
the majority of the ventilatory response to hypoxia, but they also modulate the response
to hypercapnia through changes in the parasympathetic or sympathetic systems and also
respond directly to high CO2 challenges (82, 83). Performing these experiments under
hyperoxic conditions would decrease the influence of the peripheral chemoreceptors and
might therefore unmask more of the Pet-1 knockout phenotype.
Second, there is no reason to presuppose that the phenotypic response should be
linear ie) a 70% loss of serotonergic neurons would lead to a 70% reduction in the
hypercapnic response. In fact, there are good reasons to suppose otherwise. 1) Although
a 70% reduction in the number of serotonin neurons is quantitatively impressive, this
does not address the capacity of the remaining 30%. These remaining neurons could be
simply sufficient on their own to drive a ventilatory response or they could upregulate
key transporters or enzymes as a compensatory response. Work with other
neurotransmitter systems has shown that a surprisingly small number of remaining
neurons can support essential functions. For example, in patients with unilateral
Parkinson’s Disease, imaging of the unaffected contralateral side shows a loss of up to
40% of the dopamine neurons (84). 2) Chemosensitivity is an extremely important
homeostatic mechanism, and in the absence of a normal serotonin system it is possible
that other neurotransmitter systems that normally have a minor role in chemosensitivity
could be recruited for this function. Other candidate systems could include neurons of
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the locus coeruleus (85-87), retrotrapeziod nucleus (RTN) (88, 89) or the nucleus tractus
solitarius (NTS) (90, 91). 3) There are also inherent difficulties in interpreting the results
of knockout mice. Soon after the development of homologous recombination to
eliminate target genes, many knockout mice were generated that had surprisingly normal
phenotypes given the thought-to-be essential nature of the target gene (92). In many
cases this phenotypic normality has been attributed to gene redundancy, recruitment of
alternative systems for compensation, or the superfluous nature of the target gene. This
has led to the current popularity of “conditional knockouts”, where the temporal control
over a gene allows for normal protein function during development, thus preventing
accessory or redundant systems from compensating when the protein is removed in adult
life (93). While the Pet-1 mice do exhibit a clear neuropathologic phenotype, it is not
clear what the effect of a reduction of serotonin neurons during fetal and early
development has on normal brain function.
It should be noted that every one of these caveats argues for a normalization of
phenotype, and therefore the ~25% reduction seen in ventilation and its differential
relationship to hypercapnia is an extremely strong argument for the role of serotonin
neurons in normal central chemosensitivity.

Sex Hormones and Chemosensitivity
The second goal of these experiments was to address the ability of female sex
hormones to account for the differences seen between male and female Pet-1 knockout
mice. A combination of estrogen and progesterone was used based upon work in rats
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discussed earlier that showed the need for both hormones to increase ventilation in males
and females.
A comparison of pre and post-hormone treatment total ventilation (VE) provides
no evidence that the baseline ventilation of either the wildtype or the Pet-1 knockout
group was affected by hormone therapy. This result is surprising given the extensive
evidence that progesterone is a respiratory stimulant. Unfortunately, as there is no
consensus about dosing or administration of these hormones, many of the experiments
that show the stimulatory effects of progesterone use supra-physiologic doses.
In the current study progesterone was dosed at 2 mg/kg in an attempt to
recapitulate normal female hormonal levels. In comparison, stimulation of ventilation in
female rats was achieved with MPA dosed at 8 mg/kg x 4 days (64). In order to stimulate
ventilation in male rats, they were fed TZP4238 (a progesterone analog with a potency
300-400 times that of progesterone) at 4 mg/kg, even though some respiratory effects
were seen at 0.4 mg/kg (65). For the purposes of the current study, proving the ability of
supra-physiologic progesterone to stimulate ventilation in Pet-1 mice would have had no
relevance on the experimental question. Clearly, if the female Pet-1 knockout mice are
protected by circulating sex hormones these hormones can provide adequate protection
within physiologic ranges.
While the baseline ventilation was not affected, the sex hormones did appear to
influence the ventilatory response at higher CO2 exposures. The basic pattern seen pretreatment, where ventilation at Room Air and lower CO2 exposures was diminished, was
retained only until 5% CO2 – after hormone treatment the knockout’s VE was 72%, 67%,
and 83% that of wildtype at Room Air, 3%, and 5% respectively. The ventilatory
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recovery was 97% and 99% at 7% and 10% CO2, although the caveats discussed earlier
still apply – this difference was due to a small size in the absolute ventilation of the
knockout along with a small decrease in the VE of the wildtype.
If this recovery is real and due to the hormone exposure, there are two possible
interpretations of this result: 1) The deficiency in the HCVR seen in the knockout mice
as a result of the loss of serotonin neurons can be influenced by female sex hormones, or
2) secondary chemoreceptive mechanisms are influenced by female sex hormones and
therefore “kick in” at earlier hypercapnic stresses. These are by no means mutually
exclusive, and teleologically the rescue at 7% CO2 could be explained either way. If the
remaining serotonergic neurons were enhanced by female sex hormones, this effect
would surely be seen when the neurons were receiving maximum extrinsic stimulation ie)
at the highest CO2 exposure. Similarly, redundant chemoreceptive neurons could be
recruited at lower and lower CO2 thresholds if they were responsive to sex hormones.
Neither of these options can be ruled in or out at this point, so it can therefore be
cautiously concluded that there is evidence that supplementation with physiologic levels
of female hormones can restore some of the ventilatory deficiencies seen as a result of the
loss of serotonin neurons.
Now that there is some experimental evidence that estrogen and progesterone can
manipulate the phenotype caused by reduced serotonergic neurons it is reasonable to ask
if there are other lines of evidence to support this interaction. Clear connections between
the serotonergic system and sex hormones could tip the explanatory balance towards
serotonergic neurons and away from the unknown redundant chemoreceptors.
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Due in large part to the role of the serotonin system in psychiatric disease –
mainly depression and anxiety, both of which affect females more than males (94) – the
intersection between the serotonin system and sex hormones is an active area of research
(95).
Estrogen and progesterone act through nuclear receptors – estrogen receptors in
two major isoforms ERα and ERβ (96) and progesterone isoforms PR-A and PR-B (97).
In most species studied thus far including monkey, guinea pig, and mice, ERβ is the form
that is expressed most highly in the dorsal raphe. In mice, both isoforms colocalize with
serotonin neurons (98), although ERβ has a higher rate of colocalization in the dorsal
raphe (90%) than ERα (23%) in male mice (99). Progesterone receptors in the
serotonergic neurons are upregulated by ERβ activation in both mice and monkeys and
downregulated by progesterone (100, 101).
What is known about the effects on the serotonin system of activating these
receptors? One key measure of serotonin activity is the level of TPH, which is the ratelimiting enzyme in the production of serotonin. When activated by estrogen, serotonin
neurons upregulate TPH mRNA in both guinea pigs (102) and macaques (103), and the
same effect has recently been shown in mice to be mediated through ERβ (104). Whether
this increase in mRNA results in increased TPH protein is not yet known in mice, but has
been shown to be the case in guinea pigs and macaques (102, 103).
Another regulatory target of estrogen and progesterone could be SERT, the
serotonin reuptake transporter. Treatment with estrogen increased SERT mRNA in the
dorsal raphe of rats (105) although the opposite effect (decreased SERT mRNA) was
seen in macaques (106). The physiologic effect of transport regulation is unclear
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however, since serotonin binding and uptake can be increased even the face of decreased
SERT mRNA (106). In mice, a low estrogen state led to a reduced density of SERT in
the hippocampus but a paradoxical increase in SERT activity (107). Other possible
targets for protein regulation like the 5HT1A autoreceptor (108) or MAO-A (109) show
responses to various combinations of estrogen and progesterone.
It can therefore be concluded that serotonin neurons have the basic properties
necessary to respond to female sex hormones – they express the appropriate receptors and
have the ability to regulate both mRNA and protein in response to these signals. It is
equally clear however, that invoking sex hormones to account for the difference in the
Pet-1 knockout mice requires that sex hormones be able to modulate serotonergic neural
responses.
Accordingly, a wide range of functions in which serotonin is implicated have
been shown to be modulated by female sex hormones (110). The most basic of these is a
difference in the tonic activity of dorsal raphe serotonin neurons between the sexes. In
male rats, serotonergic neurons were found to have an average firing rate 41% higher
than normal and ovariectomized females that was not correlated with circulating levels of
progesterone and estrogen. During pregnancy, the basal firing rate of the females
increased up to 136%, and this rise and subsequent fall late in pregnancy was closely
reflected in the circulating progesterone level (111). Further work by the same group
established that these differences were due to a partial desensitization of the 5-HT1A
receptors during pregnancy (112). Stimulation of the basal firing rate was achieved with
intra-cerebral ventricular DHEA, progesterone, and its metabolites in the females (113),
but these effects were not seen in males. Instead, the baseline rate in both males and
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females was modulated by testosterone as well as with estrogen (which lies downstream
from testosterone in metabolism) (114).
It would be imprudent to attempt to summarize all other actions of female sex
hormones on the serotonin system here, suffice it to say that their ability to act on it is
well-established (110).
The specific function in question here is the role of sex hormones on the serotonin
system as it pertains to breathing. There is not much experimental evidence in this area,
apart from the current study, the only work to address this question measured serotonin
levels in respiratory nuclei in male and female rats throughout their estrus cycle (38).
Females were found to have significantly higher levels of serotonin in the hypoglossal
nucleus than the males, but equal levels in the phrenic nucleus. The serotonin levels in
the different nuclei changed throughout the estrus cycle, with interesting results. In the
hypoglossal nucleus, the changes in serotonin levels closely mirror plasma estrogen,
while in the phrenic nucleus serotonin levels mirrored serum progesterone. These results
are consistent with the current study, as downstream targets would be expected to show
increased level of serotonin as the HCVR is influenced by hormonal status.
Given the enormous amount of evidence that links the serotonergic system with
female sex hormones any evidence that the knockout phenotype of the Pet-1 male mice is
altered by estrogen and progesterone must be taken seriously. The question remains
however, if it accepted that estrogen and progesterone restored some of the remaining
serotonergic function, why did they not restore all of the difference between the male and
female Pet-1 knockout mice?
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It is certainly possible that a higher dose of estrogen and progesterone could have
shown a larger impact on the ventilatory response, but this would not have addressed the
phenotypic difference between the sexes. Ovariectomy in the female mice would also
have addressed this question, but is far more invasive than hormone supplementation in
the males. Given the results of this study it is a logical follow-up experiment.
The most obvious explanation for the results is that acute supplementation with
estrogen and progesterone in male mice cannot replicate the influence of these hormones
throughout the neural and physiologic development of the female mice. There is support
for this finding in studies of the sexual dimorphism of the serotonin system, where early
in rat development (day E14) estrogen has effects on neurite growth (115). Within the
second postnatal week, there are already sex differences in the serotonergic system in
rodent brains (116). Klink et al hypothesize that the difference in the dorsal raphe basal
rate response to estrogen and progesterone is a gender-dependent trait, as the
ovariectomized female mice do not take on the male phenotype (111). If the difference
seen in the female and male Pet-1 knockout mice is due to this sort of gender-dependent
developmental mechanism then no amount of hormone supplementation would be able to
fully restore the male phenotype.
In conclusion, the present study reports that male Pet-1 knockout mice have a
variable ventilatory deficiency in response to a normoxic hypercapnic challenge, with a
decreased HCVR at lower CO2 exposures. This deficiency is partially reversed by
supplementation with physiologic levels of female sex hormones, suggesting that the
function of the remaining serotonergic neurons can be boosted by estrogen and
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progesterone and providing a partial explanation for the sparing of the female Pet-1
knockout mice hypercapnic ventilatory response.
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